Elovl2 ablation demonstrates that systemic DHA is endogenously produced and is essential for lipid homeostasis in mice

Journal of Lipid Research

Volumn 55, Issue 4, 2014, Pages 718-728

  Pauter, Anna M ^a   Olsson, Petter ^b   Asadi, Abolfazl ^a   Herslöf, Bengt ^b   Csikasz, Robert I ^a   Zadravec, Damir ^a   Jacobsson, Anders ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Docosahexaenoic acid; Elongase of very longchain fatty acid 2; Fatty acid elongase; Liver steatosis; Weight gain

Indexed keywords

ELONGATION OF VERY LONG CHAIN FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID; ACYLTRANSFERASE; DOCOSAHEXAENOIC ACID; FATTY ACID ELONGASES; SREBF1 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIMETRY; CATALYSIS; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS; LIPID ANALYSIS; LIPID COMPOSITION; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY QUOTIENT; UPREGULATION; 129 MOUSE; ANIMAL; BLOOD; DIET SUPPLEMENTATION; ENZYMOLOGY; FATTY LIVER; GENETIC TRANSCRIPTION; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM; TRANSCRIPTION INITIATION;

ACETYLTRANSFERASES; ANIMALS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FATTY LIVER; HOMEOSTASIS; LIPOGENESIS; LIVER; MALE; MICE; MICE, 129 STRAIN; MICE, KNOCKOUT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRIGLYCERIDES;

EID: 84897469592     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M046151     Document Type: Article

References (43)

1. Jump, D. B., and S. D. Clarke. 1999. Regulation of gene expression by dietary fat. Annu. Rev. Nutr. 19: 63-90.
2. Sekiya, M., N. Yahagi, T. Matsuzaka, Y. Najima, M. Nakakuki, R. Nagai, S. Ishibashi, J. Osuga, N. Yamada, and H. Shimano. 2003. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology. 38: 1529-1539.
3. González-Périz, A., R. Horrillo, N. Ferré, K. Gronert, B. Dong, E. Morán-Salvador, E. Titos, M. Martínez- Clemente, M. López-Parra, V. Arroyo, et al. 2009. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 23: 1946-1957.
4. Oosterveer, M. H., T. H. van Dijk, U. J. Tietge, T. Boer, R. Havinga, F. Stellaard, A. K. Groen, F. Kuipers, and D. J. Reijngoud. 2009. High fat feeding induces hepatic fatty acid elongation in mice. PLoS ONE. 4: e6066.
5. Burr, G. O., and M. M. Burr. 1973. Nutrition classics from The Journal of Biological Chemistry 82:345-67
6. 1929 A new deficiency disease produced by the rigid exclusion of fat from the diet. Nutr. Rev. 31: 248-249.
7. Guillou, H., D. Zadravec, P. G. Martin, and A. Jacobsson. 2010. The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice. Prog. Lipid Res. 49: 186-199.
8. Sprecher, H. 2000. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. Biophys. Acta. 1486: 219-231.
9. Voss, A., M. Reinhart, S. Sankarappa, and H. Sprecher. 1991. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19- docosahexaenoic acid in rat liver is independent of a 4-desaturase. J. Biol. Chem. 266: 19995-20000.
10. Leonard, A. E., E. G. Bobik, J. Dorado, P. E. Kroeger, L. T. Chuang, J. M. Thurmond, J. M. Parker-Barnes, T. Das, Y. S. Huang, and P. Mukerji. 2000. Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids. Biochem. J. 350: 765-770.
11. Moon, Y. A., N. A. Shah, S. Mohapatra, J. A. Warrington, and J. D. Horton. 2001. Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J. Biol. Chem. 276: 45358-45366.
12. Wang, Y., M. Torres-Gonzalez, S. Tripathy, D. Botolin, B. Christian, and D. B. Jump. 2008. Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. J. Lipid Res. 49: 1538-1552.
13. Gregory, M. K., L. G. Cleland, and M. J. James. 2013. Molecular basis for differential elongation of omega-3 docosapentaenoic acid by the rat Elovl5 and Elovl2. J. Lipid Res. 54: 2851-2857.
14. Tvrdik, P., R. Westerberg, S. Silve, A. Asadi, A. Jakobsson, B. Cannon, G. Loison, and A. Jacobsson. 2000. Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids. J. Cell Biol. 149: 707-718.
15. Ohno, Y., S. Suto, M. Yamanaka, Y. Mizutani, S. Mitsutake, Y. Igarashi, T. Sassa, and A. Kihara. 2010. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc. Natl. Acad. Sci. USA. 107: 18439-18444.
16. Tikhonenko, M., T. A. Lydic, Y. Wang, W. Chen, M. Opreanu, A. Sochacki, K. M. McSorley, R. L. Renis, T. Kern, D. B. Jump, et al. 2010. Remodeling of retinal fatty acids in an animal model of diabetes: a decrease in long chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes. 59: 219-227.
17. Zadravec, D., P. Tvrdik, H. Guillou, R. Haslam, T. Kobayashi, J. A. Napier, M. R. Capecchi, and A. Jacobsson. 2011. ELOVL2 controls the level of n-6 28:5 and 30:5 fatty acids in testis, a prerequisite for male fertility and sperm maturation in mice. J. Lipid Res. 52: 245-255.
18. Matyash, V., G. Liebisch, T. V. Kurzchalia, A. Shevchenko, and D. Schwudke. 2008. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49: 1137-1146.
19. Matthan, N. R., B. Ip, N. Resteghini, L. M. Ausman, and A. H. Lichtenstein. 2010. Long-term fatty acid stability in human serum cholesteryl ester, triglyceride, and phospholipid fractions. J. Lipid Res. 51: 2826-2832.
20. Olsson, P., J. Holmback, and B. Herslof. 2012. Separation of lipid classes by HPLC on a cyanopropyl column. Lipids. 47: 93-99.
21. Idborg, H., P. Olsson, P. Leclerc, J. Raouf, P-J. Jakobsson, and M. Korotkova. 2013. Effects of mPGES-1 deletion on eicosanoid and fatty acid profiles in mice. Prostaglandins Other Lipid Mediat. 107: 18-25.
22. Alberts, P., B. G. Johansson, and R. A. McArthur. 2006. Characterization of energy expenditure in rodents by indirect calorimetry. Curr. Protoc. Neurosci. 36: 9.23D.1-9.23D.17.
23. Lin, J., R. Yang, P. T. Tarr, P. H. Wu, C. Handschin, S. Li, W. Yang, L. Pei, M. Uldry, P. Tontonoz, et al. 2005. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell. 120: 261-273.
24. Xu, J., M. Teran-Garcia, J. H. Park, M. T. Nakamura, and S. D. Clarke. 2001. Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay. J. Biol. Chem. 276: 9800-9807.
25. Kim, H. J., M. Takahashi, and O. Ezaki. 1999. Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs. J. Biol. Chem. 274: 25892-25898.
26. Moon, Y. A., R. E. Hammer, and J. D. Horton. 2009. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J. Lipid Res. 50: 412-423.
27. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: transcriptional mediators of lipid homeostasis. Cold Spring Harb. Symp. Quant. Biol. 67: 491-498.
28. Biddinger, S. B., K. Almind, M. Miyazaki, E. Kokkotou, J. M. Ntambi, and C. R. Kahn. 2005. Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Diabetes. 54: 1314-1323.
29. Kobayashi, T., D. Zadravec, and A. Jacobsson. 2007. ELOVL2 overexpression enhances triacylglycerol synthesis in 3T3-L1 and F442A cells. FEBS Lett. 581: 3157-3163.
30. Stoffel, W., B. Holz, B. Jenke, E. Binczek, R. H. Gunter, C. Kiss, I. Karakesisoglou, M. Thevis, A. A. Weber, S. Arnhold, et al. 2008. Delta6-desaturase (FADS2) deficiency unveils the role of omega3-and omega6-polyunsaturated fatty acids. EMBO J. 27: 2281-2292.
31. Stroud, C. K., T. Y. Nara, M. Roqueta-Rivera, E. C. Radlowski, P. Lawrence, Y. Zhang, B. H. Cho, M. Segre, R. A. Hess, J. T. Brenna, et al. 2009. Disruption of FADS2 gene in mice impairs male reproduction and causes dermal and intestinal ulceration. J. Lipid Res. 50: 1870-1880.
32. Sato, A., H. Kawano, T. Notsu, M. Ohta, M. Nakakuki, K. Mizuguchi, M. Itoh, T. Suganami, and Y. Ogawa. 2010. Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes. 59: 2495-2504.
33. Liu, X., Y. Xue, C. Liu, Q. Lou, J. Wang, T. Yanagita, C. Xue, and Y. Wang. 2013. Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice. Lipids Health. Dis. 12: 109.
34. Lu, J., F. Borthwick, Z. Hassanali, Y. Wang, R. Mangat, M. Ruth, D. Shi, A. Jaeschke, J. C. Russell, C. J. Field, et al. 2011. Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA-cp rat model of the metabolic syndrome. Br. J. Nutr. 105: 1572-1582.
35. Pachikian, B. D., A. Essaghir, J. B. Demoulin, A. M. Neyrinck, E. Catry, F. C. De Backer, N. Dejeans, E. M. Dewulf, F. M. Sohet, L. Portois, et al. 2011. Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets. PLoS ONE. 6: e23365.
36. Beale, E. G., B. J. Harvey, and C. Forest. 2007. PCK1 and PCK2 as candidate diabetes and obesity genes. Cell Biochem. Biophys. 48: 89-95.
37. Millward, C. A., D. Desantis, C. W. Hsieh, J. D. Heaney, S. Pisano, Y. Olswang, L. Reshef, M. Beidelschies, M. Puchowicz, and C. M. Croniger. 2010. Phosphoenolpyruvate carboxykinase (Pck1) helps regulate the triglyceride/fatty acid cycle and development of insulin resistance in mice. J. Lipid Res. 51: 1452-1463.
38. Cohen, P., M. Miyazaki, N. D. Socci, A. Hagge-Greenberg, W. Liedtke, A. A. Soukas, R. Sharma, L. C. Hudgins, J. M. Ntambi, and J. M. Friedman. 2002. Role for stearoyl-CoA desaturase-1 in leptinmediated weight loss. Science. 297: 240-243.
39. Ntambi, J. M., M. Miyazaki, J. P. Stoehr, H. Lan, C. M. Kendziorski, B. S. Yandell, Y. Song, P. Cohen, J. M. Friedman, and A. D. Attie. 2002. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. USA. 99: 11482-11486.
40. Biddinger, S. B., M. Miyazaki, J. Boucher, J. M. Ntambi, and C. R. Kahn. 2006. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c. Diabetes. 55: 2032-2041.
41. Miyazaki, M., M. T. Flowers, H. Sampath, K. Chu, C. Otzelberger, X. Liu, and J. M. Ntambi. 2007. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab. 6: 484-496.
42. Tanaka, T., J. Shen, G. R. Abecasis, A. Kisialiou, J. M. Ordovas, J. M. Guralnik, A. Singleton, S. Bandinelli, A. Cherubini, D. Arnett, et al. 2009. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet. 5: e1000338.
43. Illig, T., C. Gieger, G. Zhai, W. Romisch-Margl, R. Wang-Sattler, C. Prehn, E. Altmaier, G. Kastenmuller, B. S. Kato, H. W. Mewes, et al. 2010. A genome-wide perspective of genetic variation in human metabolism. Nat. Genet. 42: 137-141.